ATON Overview

AlphaTON Capital Corp., formerly Portage Biotech Inc., is a specialized digital asset treasury company. The Company is focused on building and managing a strategic reserve of The Open Network (TON) tokens and developing the Telegram ecosystem. The Company implements a treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, the Company provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform. It is also advancing therapies that target known checkpoint resistance pathways to achieve durable treatment response and improve quality of life for patients. The Company engages in the drug development process and provides strategic counsel to guide development of immunotherapy assets and asset combinations.

Wall Street analysts forecast ATON stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATON is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

AlphaTON Capital Corp revenue for the last quarter amounts to -4.50M USD, increased 179.52

AlphaTON Capital Corp. EPS for the last quarter amounts to USD, decreased -100.00

AlphaTON Capital Corp (ATON) has 3 emplpoyees as of April 16 2026.

Today ATON has the market capitalization of 7.94M USD.